Opportunity assessments are used to inform a wide variety of important business decisions for life sciences companies, including product, operational, and investment decisions. However, developing accurate assessments can be notoriously challenging in today’s ever evolving and increasingly competitive healthcare environment. Epidemiology sources, primary research, and other traditional sources are key components to understanding pivotal forecast components, but these data points can be time consuming to aggregate and frustrating to validate, especially for complex and changing markets. Real-world data (RWD), on the other hand, is readily available in the current healthcare environment and is grounded in reality.
In complex and dynamic markets, real-world data sources can be leveraged to generate more accurate and insightful forecasts compared to traditional methods – by modeling the true size of a patient population, market dynamics, changes over time, and more. Deep forecasting experience and a detailed knowledge of data sources can alleviate initial challenges in incorporating real-world data into valuations and communicating resulting outputs to key stakeholders.
This webinar will show how RWD can be leveraged to improve confidence in opportunity assessments and better inform strategic decision-making. We will walk through the multiple ways to innovatively apply RWD to strategic business questions, presenting IQVIA case studies to highlight the methodologies and insights that can inform the assessment process.